How can my business apply for NIH SBIR Biotech Grants 2026-2027 in 2026?
The Short Answer: To apply for NIH SBIR Biotech Grants 2026-2027, start by reviewing the eligibility criteria and preparing a project proposal. Complete 2026-2027 guide to NIH SBIR/STTR grants for biotech startups. Phase I up to $285K, Phase II up to $2M for therapeutics, medical devices, diagnostics, digital health innovation. Funding available: up to $285K (with related programs offering $2M).
AI Summary & Key Takeaways
- Overview: A comprehensive guide covering the latest updates, funding amounts, and application strategies for NIH SBIR Biotech Grants 2026-2027 | $285K Phase I, $2M Phase II Medical Device & Digital Health Funding.
- Category Focus: This essential research brief targets USA News and explores funding impacts related to business growth.
- Actionable Intelligence: Readers will discover verified eligibility requirements, internal program mechanics, and timeline expectations within this concise 10 min read read.
"Am I Eligible?" Micro-Quiz
Take 10 seconds to answer these questions and instantly see if you meet the baseline criteria for this funding.
Quickly compare the highest-value funding options available.
| Program Name | Max Amount | Equity Req. | Best For | Timeline |
|---|---|---|---|---|
| Core NIH SBIR Biotech Grants -2027 | Phase I, Phase II Medical Device & Digital Health Funding Grant | $285K | Non-dilutive | Eligible Applicants | Standard Review |
| Related Provincial Match | Up to 50% | 0% | Expansion Projects | 45 Days |
| Federal Support Program | Varies | Non-dilutive | Scaling Businesses | 90 Days |
Scientific Rigor
NIH SBIR and STTR Program Details 2026-2027
Complete breakdown of Phase I, Phase II funding programs with biotech topic areas and application timelines
Phase I Program Overview
Phase I Biotech Objectives:
• Scientific Feasibility: Prove biological mechanism, efficacy, safety at preclinical or early clinical stage
• Clinical Relevance: Demonstrate technology addresses unmet medical need with clear patient benefit
• Regulatory Pathway: Identify FDA approval pathway (510k, PMA, IND) and key regulatory milestones
• IP Protection: File provisional patents protecting innovation before public disclosure
• Market Validation: Engage physicians, KOLs, payers validating clinical need and reimbursement potential
Phase I Success Stories - Biotech
💊 Cambridge Drug Discovery - $285K Phase I
Massachusetts biotech received NIH Phase I for novel small molecule targeting oncology validated through in vivo tumor regression studies. Partnered with 2 academic medical centers for Phase II clinical preparation.
Location: Cambridge MA | Tech: Therapeutics | Phase II: Funded $2M
💊 SF Medical Device - $280K Phase I Grant
California medical device startup obtained NIH SBIR Phase I for minimally invasive surgical tool reducing complications 60% validated through cadaver studies. 510k pathway identified with FDA pre-submission meeting completed.
Location: San Francisco CA | Tech: Medical Device | FDA: 510k pathway
💊 Boston Diagnostics - $285K Phase I Award
Massachusetts diagnostics company secured NIH Phase I for rapid infectious disease test achieving 98% sensitivity/specificity in 15 minutes vs 3-day culture. CLIA waiver pathway with 3 hospital pilot sites committed.
Location: Boston MA | Tech: Diagnostics | Accuracy: 98% sensitivity
💊 Seattle Digital Health - $275K Phase I Funding
Washington digital health platform received NIH SBIR for AI-powered remote patient monitoring reducing hospital readmissions 40% validated through 200-patient retrospective study. De novo FDA pathway with CE mark obtained.
Location: Seattle WA | Tech: Digital Health | Impact: -40% readmissions
📍 NIH SBIR Phase I Application Deadlines 2026-2027
Standard Deadlines:
- • January 5, 2026
- • April 5, 2026
- • September 5, 2026
- • January 5, 2027
Review Timeline:
- • Initial review: 2 months
- • Council review: 4 months
- • Award decision: 6-7 months
- • Project start: Month 8
Fast-Track Option:
- • Direct Phase II possible
- • $50K+ investor commitment
- • Combined $1.15M funding
- • Accelerated timeline
Visit seed.nih.gov for exact submission dates across 27 NIH institutes[web:161][web:185]
Phase II Program Overview
Phase II Biotech Activities:
- • Clinical trials (Phase I/II human studies)
- • FDA regulatory submissions (IND, IDE, 510k)
- • Manufacturing scale-up and GMP validation
- • Reimbursement strategy and health economics
- • Commercial partnerships and licensing deals
Phase II Success Stories
💎 Boston Therapeutics - $2M Phase II + Series A
Massachusetts drug company received $2M NIH Phase II for rare disease therapy completing Phase Ib clinical trial. Subsequently raised $15M Series A from top biotech VCs, advancing to Phase II pivotal trial. FDA orphan drug designation obtained.
Location: Boston MA | Clinical: Phase II | Raise: $15M Series A
💎 SF Medical Device - $1.8M Phase II Award
California medical device startup obtained $1.8M NIH Phase II for cardiac intervention device completing 50-patient first-in-human study. FDA PMA pathway, CE mark approved, launched Europe generating $5M revenue. Acquired by medical device giant for $85M.
Location: San Francisco CA | Exit: $85M acquisition | Revenue: $5M
💎 San Diego Diagnostics - $1.5M Phase II Funding
California diagnostics company secured $1.5M NIH Phase II for cancer liquid biopsy test achieving 95% sensitivity in 500-patient validation study. CLIA lab certified, serving 20 hospitals, pre-IPO stage with $25M revenue run-rate and Medicare reimbursement approved.
Location: San Diego CA | Revenue: $25M ARR | Status: Pre-IPO
Major Institutes:
- • NCI: Cancer therapeutics, diagnostics, immunotherapy
- • NHLBI: Cardiovascular, pulmonary, blood disorders
- • NIAID: Infectious disease, vaccines, immunology
- • NINDS: Neurological disorders, brain health
- • NIDDK: Diabetes, kidney, digestive diseases
Medical Devices:
- • NIBIB: Biomedical imaging, medical devices
- • NICHD: Pediatric devices, maternal health
- • NEI: Vision, ophthalmology devices
- • NIDCD: Hearing, communication devices
- • NIAMS: Orthopedic, musculoskeletal devices
Digital Health:
- • Remote patient monitoring platforms
- • AI-powered diagnostics and decision support
- • Telemedicine and virtual care solutions
- • Wearable sensors and health tracking
- • Electronic health records and data analytics
💡Need expert help applying for grants?
Our funding specialists can help you navigate government programs and maximize your funding potential.
Frequently Asked Questions
Related Grants You May Like
Same TopicSBA SBIR/STTR 2026: America's Seed Fund for Startups
🇺🇸 Detailed guide to the Small Business Innovation Research (SBIR) program. How to access over $4 billion in non-dilutive R&D funding in 2026.
Same TopicUSDA Rural Business Development Grants 2026 | Funding Guide
🇺🇸 Support for rural entrepreneurs. The USDA provides grants for training, equipment, and real estate in eligible rural areas.
Same TopicHUD Community Development Grants 2026: $150M CDBG Guide
HUD's CDBG program provides $150 million for community development. Learn how local governments and nonprofits can access funds for housing, infrastructure, and economic development.